Suppr超能文献

糖尿病合并病态肥胖患者的减肥手术:一项基于证据的分析。

Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis.

出版信息

Ont Health Technol Assess Ser. 2009;9(22):1-23. Epub 2009 Oct 1.

Abstract

UNLABELLED

In June 2008, the Medical Advisory Secretariat began work on the Diabetes Strategy Evidence Project, an evidence-based review of the literature surrounding strategies for successful management and treatment of diabetes. This project came about when the Health System Strategy Division at the Ministry of Health and Long-Term Care subsequently asked the secretariat to provide an evidentiary platform for the Ministry's newly released Diabetes Strategy.After an initial review of the strategy and consultation with experts, the secretariat identified five key areas in which evidence was needed. Evidence-based analyses have been prepared for each of these five areas: insulin pumps, behavioural interventions, bariatric surgery, home telemonitoring, and community based care. For each area, an economic analysis was completed where appropriate and is described in a separate report.To review these titles within the Diabetes Strategy Evidence series, please visit the Medical Advisory Secretariat Web site, http://www.health.gov.on.ca/english/providers/program/mas/masabout.html,DIABETES STRATEGY EVIDENCE PLATFORM: Summary of Evidence-Based AnalysesContinuous Subcutaneous Insulin Infusion Pumps for Type 1 and Type 2 Adult Diabetics: An Evidence-Based AnalysisBehavioural Interventions for Type 2 Diabetes: An Evidence-Based AnalysisBARIATRIC SURGERY FOR PEOPLE WITH DIABETES AND MORBID OBESITY: An Evidence-Based SummaryCommunity-Based Care for the Management of Type 2 Diabetes: An Evidence-Based AnalysisHome Telemonitoring for Type 2 Diabetes: An Evidence-Based AnalysisApplication of the Ontario Diabetes Economic Model (ODEM) to Determine the Cost-effectiveness and Budget Impact of Selected Type 2 Diabetes Interventions in Ontario

OBJECTIVE

The purpose of this evidence-based analysis was to examine the effectiveness and cost-effectiveness of bariatric surgery for the management of diabetes in morbidly obese people. This report summarized evidence specific to bariatric surgery and the improvement of diabetes from the full evidence-based analysis of bariatric surgery for the treatment of morbid obesity completed by the Medical Advisory Secretariat (MAS) in January 2005. To view the full report, please visit the MAS website at: http://www.health.gov.on.ca/english/providers/program/mas/tech/techmn.html.

CLINICAL NEED

CONDITION AND TARGET POPULATION Obesity is defined as an excessive accumulation of body fat as measured by the body mass index (BMI) and calculated as body weight in kilograms (kg) divided by height in metres squared (m(2)). People with a BMI over 30 kg/m(2) are considered obese in most countries. The condition is associated with the development of several diseases, including hypertension, diabetes mellitus (type 2 diabetes), hyperlipidemia, coronary artery disease, obstructive sleep apnea, depression, and cancers of the breast, uterus, prostate, and colon. Clinically severe, or morbid obesity, is commonly defined by a BMI of at least 40 kg/m(2), or a BMI of at least 35 kg/m(2) if there are comorbid conditions such as diabetes, cardiovascular disease, or arthritis. The prevalence of morbid obesity among people with type 2 diabetes has been examined and of 2,460 patients with type 2 diabetes, 52% (n = 1,279) were obese (BMI ≥ 30 kg/m(2)) and 23% (n = 561) had a BMI ≥ 35 kg/m(2). BARIATRIC SURGERY: Men and women with morbid obesity may be eligible for surgical intervention. There are numerous surgical options available, all of which can be divided into two general types, both of which can be performed either as open surgery or laparoscopically: malabsorptive - bypassing parts of the gastrointestinal tract to limit the absorption of food, andrestrictive - decreasing the size of the stomach in order for the patient to feel satiated with a smaller amount foodSurgery for morbid obesity is usually considered a last resort for people who have attempted first-line medical management (e.g. diet, behaviour modification, increased physical activity, and drugs) but who have not lost weight permanently. Surgery is restricted to people with morbid obesity (BMI ≥ 40 kg/m(2)) or those with a BMI of at least 35 kg/m(2) and serious comorbid conditions.

EVIDENCE-BASED ANALYSIS METHODS: Details of the full literature search can be found in the 2005 evidence-based analysis of bariatric surgery (http://www.health.gov.on.ca/english/providers/program/mas/tech/techmn.html). Briefly, a literature search was conducted examining published works from January 1996 to December 2004, including OVID MEDLINE, MEDLINE In-Process and Other Non-Indexed Citations, EMBASE, the Cumulative Index to Nursing & Allied Health Literature (CINAHL), The Cochrane Library, and the International Agency for Health Technology Assessment/Centre for Review and Dissemination.

INCLUSION CRITERIA

Data on the effectiveness or cost-effectiveness of bariatric surgery for the improvement of diabetesSystematic reviews, randomized controlled trials (RCTs), and observational controlled prospective studies that had >100 patientsRandomized controlled trials (RCTs), systematic reviews and meta-analyses

EXCLUSION CRITERIA

Duplicate publications (superseded by another publication by the same investigator group, with the same objective and data)Non-English-language articlesNon-systematic reviews, letters, and editorialsAnimal and in-vitro studiesCase reports, case seriesStudies that did not examine the outcomes of interest

OUTCOMES OF INTEREST

Improvement or resolution of diabetesThe quality of the studies was examined according to the GRADE Working Group criteria for grading quality of evidence.

SUMMARY OF FINDINGS

There is evidence that bariatric surgery is effective for improvement and resolution of diabetes in patients who are morbidly obese (BMI≥35 kg/m(2)). The quality of evidence for the use of bariatric surgery for the resolution or improvement of diabetes in morbidly obese people, according to the GRADE quality-of-evidence criteria, was found to be moderate (see ES Table 1). Comparison of various bariatric techniques: No prospective, long-term direct comparison is available between malabsorptive and restrictive techniques.Retrospective subgroup analyses from a large observational study showed greater improvement and resolution of diabetes using malabsorptive techniques rather than purely restrictive methods.There is evidence from a meta-analysis that malabsorptive techniques are better than other banding techniques in terms of improvement and resolution of diabetes.

KEYWORDS

Bariatric surgery, morbid obesity, comorbidity, diabetes ES Table 1:GRADE Quality of Evidence for Bariatric Surgery for the Resolution or Improvement of DiabetesOutcomeQuality AssessmentSummary of FindingsDesignQualityConsistencyDirectnessOtherNo. of PatientsEffectQualityImprovement in HbA1c indiabetic and glucoseintolerant patientsMeta-analysisModerateConsistentDirectNonen=171-2.70% (-5.0% to -0.70%)weighted mean change(range)ModerateResolution or improvement of diabetes(Studies reporting combinationas well as studies that only usedthe term "improved", but not thestudies reporting only resolution)Meta-analysisModerateConsistentDirectNone414/485(n resolved orimproved/nevaluated)86.0% (78.4% to 93.7%)mean% (95% CI)ModerateResolution of diabetes(diabetes disappeared or nolonger required therapy)Meta-analysisModerateConsistentDirectNone1417/1846(n resolved/nevaluated)76.8% (70.7% to 82.9%)mean% (95% CI)ModerateRecovery of diabetes(fasting plasma glucose level ofless than 126 mg per decilitre[7.0 mmol per litre])Observationalprospectivecontrolled studyModerateConsistentSomeuncertainty(†)Someuncertainty(‡)control n=84intervention n=1183.45 (1.64 to 7.28)OR (95% CI) at 10 yrsModerate*Downgraded due to study design (not randomized controlled trial)†Unlikely to be an important uncertainty. Inclusion criteria for the SOS study not specific to conventional definition of "morbidly obese" patients (BMI ≥ 40 or ≥ 35 kg/m(2) with comorbid conditions)‡Unlikely to be an important uncertainty. Control group not standardized, however, this lends to the pragmatic nature of the study.

摘要

未标注

2008年6月,医学咨询秘书处开始了糖尿病策略证据项目的工作,这是一项对有关糖尿病成功管理和治疗策略的文献进行的循证综述。该项目始于卫生和长期护理部的卫生系统策略司随后要求秘书处为该部新发布的糖尿病策略提供一个证据平台。在对该策略进行初步审查并与专家协商后,秘书处确定了五个需要证据的关键领域。已针对这五个领域中的每一个领域进行了循证分析:胰岛素泵、行为干预、减肥手术、家庭远程监测和社区护理。对于每个领域,在适当情况下完成了经济分析,并在一份单独的报告中进行了描述。要查看糖尿病策略证据系列中的这些标题,请访问医学咨询秘书处网站,网址为:http://www.health.gov.on.ca/english/providers/program/mas/masabout.html,糖尿病策略证据平台:循证分析总结,1型和2型成年糖尿病患者的持续皮下胰岛素输注泵:循证分析,2型糖尿病的行为干预:循证分析,糖尿病合并病态肥胖患者的减肥手术:循证总结,2型糖尿病管理的社区护理:循证分析,2型糖尿病的家庭远程监测:循证分析,安大略省糖尿病经济模型(ODEM)在确定安大略省选定的2型糖尿病干预措施的成本效益和预算影响方面的应用

目的

本循证分析的目的是研究减肥手术对病态肥胖人群糖尿病管理的有效性和成本效益。本报告总结了2005年1月医学咨询秘书处(MAS)完成的减肥手术治疗病态肥胖的完整循证分析中减肥手术及糖尿病改善情况的具体证据。要查看完整报告,请访问MAS网站:http://www.health.gov.on.ca/english/providers/program/mas/tech/techmn.html。

临床需求

病情和目标人群,肥胖定义为通过体重指数(BMI)衡量的身体脂肪过度积累,计算方法为体重(千克,kg)除以身高的平方(米²,m(2))。在大多数国家,BMI超过30 kg/m(2)的人被视为肥胖。这种情况与多种疾病的发生有关,包括高血压、糖尿病(2型糖尿病)、高脂血症、冠状动脉疾病、阻塞性睡眠呼吸暂停、抑郁症以及乳腺癌、子宫癌、前列腺癌和结肠癌。临床上严重的肥胖,即病态肥胖,通常定义为BMI至少为40 kg/m(2),如果存在糖尿病、心血管疾病或关节炎等合并症,则BMI至少为35 kg/m(2)。已对2型糖尿病患者中的病态肥胖患病率进行了研究,在2460例2型糖尿病患者中,52%(n = 1279)肥胖(BMI≥30 kg/m(2)),23%(n = 561)的BMI≥35 kg/m(2)。减肥手术:病态肥胖的男性和女性可能有资格接受手术干预。有多种手术选择,所有这些选择都可分为两大类,两类都可通过开放手术或腹腔镜手术进行:吸收不良型 - 绕过部分胃肠道以限制食物吸收,和限制型 - 减小胃的大小以使患者用较少的食物量就感到饱足。病态肥胖的手术通常被认为是那些尝试过一线医疗管理(如饮食、行为改变、增加体育活动和药物)但未永久减重的人的最后手段。手术仅限于病态肥胖(BMI≥40 kg/m(2))或BMI至少为35 kg/m(2)且有严重合并症的人。

循证分析方法

完整文献检索的详细信息可在2005年减肥手术的循证分析中找到(http://www.health.gov.on.ca/english/providers/program/mas/tech/techmn.html)。简而言之,进行了文献检索,研究了1996年1月至

相似文献

1
Bariatric surgery for people with diabetes and morbid obesity: an evidence-based analysis.
Ont Health Technol Assess Ser. 2009;9(22):1-23. Epub 2009 Oct 1.
2
Community-based care for the management of type 2 diabetes: an evidence-based analysis.
Ont Health Technol Assess Ser. 2009;9(23):1-40. Epub 2009 Oct 1.
4
Home telemonitoring for type 2 diabetes: an evidence-based analysis.
Ont Health Technol Assess Ser. 2009;9(24):1-38. Epub 2009 Oct 1.
5
Behavioural interventions for type 2 diabetes: an evidence-based analysis.
Ont Health Technol Assess Ser. 2009;9(21):1-45. Epub 2009 Oct 1.
6
Bariatric surgery: an evidence-based analysis.
Ont Health Technol Assess Ser. 2005;5(1):1-148. Epub 2005 Jan 1.
9
10
Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
Ont Health Technol Assess Ser. 2009;9(10):1-40. Epub 2009 Sep 1.

引用本文的文献

1
First-World Care at Third-World Rates: Pakistan, an Attractive Destination for Bariatric Tourism.
Cureus. 2023 Nov 9;15(11):e48572. doi: 10.7759/cureus.48572. eCollection 2023 Nov.
2
Madecassoside Inhibits Body Weight Gain Modulating SIRT1-AMPK Signaling Pathway and Activating Genes Related to Thermogenesis.
Front Endocrinol (Lausanne). 2021 Mar 9;12:627950. doi: 10.3389/fendo.2021.627950. eCollection 2021.
4
Bariatric Surgery Coverage: a Comprehensive Budget Impact Analysis from a Payer Perspective.
Obes Surg. 2018 Jun;28(6):1711-1723. doi: 10.1007/s11695-017-3085-8.
6
The Role of Sleeve Gastrectomy on Preventing Type 2 Diabetes Mellitus.
Open Access Maced J Med Sci. 2017 Jun 11;5(3):316-318. doi: 10.3889/oamjms.2017.074. eCollection 2017 Jun 15.
9
Cost-effectiveness of a shared computerized decision support system for diabetes linked to electronic medical records.
J Am Med Inform Assoc. 2012 May-Jun;19(3):341-5. doi: 10.1136/amiajnl-2011-000371. Epub 2011 Nov 3.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验